collection
MENU ▼
Read by QxMD icon Read
search

azacitidine

shared collection
4 papers 0 to 25 followers vidaza
https://www.readbyqxmd.com/read/27829292/efficacy-of-azacitidine-in-the-treatment-of-adult-patients-aged-65-years-or-older-with-aml
#1
Elena Tenti, Cristina Papayannidis, Giovanni Marconi, Sarah Parisi, Giorgia Simonetti, Stefania Paolini, Chiara Sartor, Emanuela Ottaviani, Nicoletta Testoni, Giovanni Martinelli
Therapy for acute myeloid leukemia (AML) in elderly populations (>65 years) is still a challenge for scientists and hematologists worldwide, and represents an urgent medical need. Notably, the identification and the recognition of molecular and epigenetic mechanisms involved in the pathogenesis of such a heterogeneous disease, are providing new tools for a more successful and 'targeted' approach. Azacitidine is a hypomethylating agent (HMA) with relevant activity in patients affected by myelodysplastic syndrome (MDS) and AML with low blast cells percentage (>30%), in terms of reduction of transfusion dependence, and improvement of quality of life...
December 2016: Expert Opinion on Pharmacotherapy
https://www.readbyqxmd.com/read/25042977/comparison-between-decitabine-and-azacitidine-for-the-treatment-of-myelodysplastic-syndrome-a-meta-analysis-with-1-392-participants
#2
REVIEW
Mixue Xie, Qi Jiang, Yanhui Xie
The hypomethylating agents decitabine and azacitidine have been found to improve the outcome of patients with myelodysplastic syndrome (MDS); however, the clinical choice between them is controversial. Therefore, this meta-analysis was performed to compare the efficacy, toxicity, and survival advantage of decitabine and azacitidine in patients with MDS. Eleven trials with a total of 1392 patients with MDS (decitabine, n = 768; azacitidine, n = 624) were included for analysis. The pooled estimates of partial response, hematologic improvement, and overall response rates for azacitidine were significantly higher than for decitabine...
January 2015: Clinical Lymphoma, Myeloma & Leukemia
https://www.readbyqxmd.com/read/27540140/response-to-treatment-with-azacitidine-in-children-with-advanced-myelodysplastic-syndrome-prior-to-hematopoietic-stem-cell-transplantation
#3
Nicolas Waespe, Machiel Van Den Akker, Robert J Klaassen, Lani Lieberman, Meredith S Irwin, Salah S Ali, Mohamed Abdelhaleem, Bozana Zlateska, Mira Liebman, Michaela Cada, Tal Schechter, Yigal Dror
Advanced myelodysplastic syndrome harbors a high risk of progression to acute myeloid leukemia and poor prognosis. In children, there is no established treatment to prevent or delay progression to leukemia prior to hematopoietic stem cell transplantation. Azacitidine is a hypomethylating agent, which was shown to slow progression to leukemia in adults with myelodysplastic syndrome. There is little data on the efficacy of azacitidine in children. We reviewed 22 pediatric patients with advanced myelodysplastic syndrome from a single center, diagnosed between January 2000 and December 2015...
December 2016: Haematologica
https://www.readbyqxmd.com/read/23713435/optimizing-outcomes-following-allogeneic-hematopoietic-progenitor-cell-transplantation-in-aml-the-role-of-hypomethylating-agents
#4
REVIEW
Massimo Martino, Roberta Fedele, Tiziana Moscato, Francesca Ronco
Aberrant DNA methylation is a key pathological mechanism in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), and provides rationale for the clinical development of hypomethylating agents (HMAs) for the treatment of these diseases. One HMA, azacitidine (Vidaza®, Celgene Corp.), has demonstrated improved survival versus conventional care regimens in patients with intermediate-2/high-risk MDS and AML (20-30% blasts) and has a favorable tolerability profile. Emerging evidence indicates that azacitidine can have an immunomodulatory effect by, for example, increasing functional regulatory T-cell (Treg) numbers and killer-cell-immunoglobulin-like receptor expression...
July 2013: Current Cancer Drug Targets
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"